 |
|
|
REFERENCES
151.
Meier GD, Bove AA, Santamore WP, Lynch PR: Contractile
function in canine right ventricle. Am J Physiol 239:H794–H804, 1980.
152.
Pouleur H, Lefevre J, van Mechelen H, Charlier
AA: Free wall shortening and relaxation during ejection in the canine right ventricle.
Am J Physiol 239:H601–H613, 1980.
153.
Tobin JR Jr, Blundell PE, Goodrich RG, Swan HJC:
Induced pressure gradients across infundibular zone of right ventricle in normal
dogs. Circ Res 16:162–173, 1965.
154.
Myhre ESP, Slinker BK, LeWinter MM: Absence of
right ventricular isovolumic relaxation in open-chest anesthetized dogs. Am J Physiol
263:H1587–H1590, 1992.
155.
Priebe HJ: Effects of halothane on global and
regional biventricular performances and on coronary hemodynamics before and during
right coronary artery stenosis in the dog. Anesthesiology 78:541–552, 1993.
156.
Heerdt PM, Pleimann BE: The dose-dependent effects
of halothane on right ventricular contraction pattern and regional inotropy in swine.
Anesth Analg 82:1152–1158, 1996.
157.
Nolan SP, Dixon SH Jr, Fisher RD, Morrow AG:
The influence of atrial contraction and mitral valve mechanics on ventricular filling.
A study of instantaneous mitral valve flow in vivo. Am Heart J 77:784–791,
1969.
158.
Ruskin J, McHale PA, Harley A, Greenfield JC Jr:
Pressure-flow studies in man: Effect of atrial systole on left ventricular function.
J Clin Invest 49:472–478, 1970.
159.
Grant C, Bunnell IL, Greene DG: The reservoir
function of the left atrium during ventricular systole: An angiocardiographic study
of atrial stroke volume and work. Am J Med 37:36–43, 1964.
160.
Ishida Y, Meisner JS, Tsujioka K, et al: Left
ventricular filling dynamics: Influence of left ventricular relaxation and left
atrial pressure. Circulation 74:187–196, 1986.
161.
Suga H: Importance of atrial compliance in cardiac
performance. Circ Res 35:39–43, 1974.
162.
Pagel PS, Kehl F, Gare M, et al: Mechanical function
of the left atrium: New insights based on analysis of pressure-volume relations
and Doppler echocardiography. Anesthesiology 98:975–994, 2003.
163.
Paradise RR, Griffith LK: Influence of halothane,
chloroform and methoxyflurane on potassium content of rat atria. Anesthesiology
26:195–198, 1965.
164.
Ko KC, Paradise RR: The effects of substrates
on contractility of rat atria depressed with halothane. Anesthesiology 31:532–539,
1969.
165.
Ko KC, Paradise RR: Multiple mechanisms of action
of halothane and methoxyflurane on force of contraction of isolated rat atria. Anesthesiology
39:278–284, 1973.
166.
Seifen AB, Kennedy RH, Seifen E: Effects of volatile
anesthetics on response to norepinephrine and acetylcholine in guinea pig atria.
Anesth Analg 73:304–309, 1991.
167.
Ko KC, Paradise RR: The effects of substrates
on halothane-depressed isolated human atria. Anesthesiology 33:508–514, 1970.
168.
Luk HN, Lin CI, Wei J, Chang CL: Depressant effects
of isoflurane and halothane on isolated human atrial fibers. Anesthesiology 69:667–676,
1988.
169.
Hanouz JL, Massetti M, Guesne G, et al: In vitro
effects of desflurane, sevoflurane, isoflurane, and halothane in isolated human right
atria. Anesthesiology 92:116–124, 2000.
170.
Pagel PS, Farber NE, Warltier DC: Cardiovascular
pharmacology. In Miller RD (ed): Anesthesia, 5th
ed. Philadelphia, Churchill Livingstone, 2000, pp 96–124.
171.
Gare M, Schwabe DA, Hettrick DA, et al: Desflurane,
sevoflurane, and isoflurane affect left atrial active and passive mechanical properties
and impair left atrial-left ventricular coupling in vivo: Analysis using pressure-volume
relations. Anesthesiology 95:689–698, 2001.
172.
Barbier P, Solomon SB, Schiller NB, Glantz SA:
Left atrial relaxation and left ventricular systolic function determine left atrial
reservoir function. Circulation 100:427–436, 1999.
173.
Bosnjak ZJ, Kampine JP: Effects of halothane,
enflurane, and isoflurane in the SA node. Anesthesiology 58:314–321, 1983.
174.
Bristow JD, Prys-Roberts C, Fisher A, et al:
Effects of anesthesia on baroreflex control of heart rate in man. Anesthesiology
31:422–428, 1969.
175.
Kotrly KJ, Ebert TJ, Vucins E, et al: Baroreceptor
reflex control of heart rate during isoflurane anesthesia in humans. Anesthesiology
60:173–179, 1984.
176.
Bagshaw RJ, Cox RH: Baroreceptor control of systemic
haemodynamics at incremental halothane levels in the dog. Acta Anaesthesiol Scand
25:416–420, 1981.
177.
Duke PC, Fownes D, Wade JG: Halothane depresses
baroreflex control of heart rate in man. Anesthesiology 46:184–187, 1977.
178.
Ebert TJ, Kotrly KJ, Vucins EJ, et al: Halothane
attenuates cardiopulmonary baroreflex control of peripheral resistance in humans.
Anesthesiology 63:668–674, 1985.
179.
Calverley RK, Smith NT, Jones CW, et al: Ventilatory
and cardiovascular effects of enflurane anesthesia during spontaneous ventilation
in man. Anesth Analg 57:610–618, 1978.
180.
Weiskopf RB, Cahalan MK, Ionescu P, et al: Cardiovascular
actions of desflurane with and without nitrous oxide during spontaneous ventilation
in humans. Anesth Analg 73:165–174, 1991.
181.
Murat I, Lapeyre G, Saint-Maurice C: Isoflurane
attenuates baroreflex control of heart rate in human neonates. Anesthesiology 70:395–400,
1989.
182.
Cahalan MK, Lurz FW, Eger EI II, et al: Narcotics
decrease heart rate during inhalational anesthesia. Anesth Analg 66:166–170,
1987.
183.
Mallow JE, White RD, Cucchiara RF, Tarhan S:
Hemodynamic effects of isoflurane and halothane in patients with coronary artery
disease. Anesth Analg 55:135–138, 1976.
184.
Holaday DA, Smith FR: Clinical characteristics
and biotransformation of sevoflurane in healthy human volunteers. Anesthesiology
54:100–106, 1981.
185.
Kasuda H, Akazawa S, Shimizu R: The echocardiographic
assessment of left ventricular performance during sevoflurane and halothane anesthesia.
J Anesth 4:295–302, 1990.
186.
Ebert TJ, Harkin CP, Muzi M: Cardiovascular responses
to sevoflurane: A review. Anesth Analg 81:S11–S22, 1995.
187.
Frink EJ Jr, Malan TP, Atlas M, et al: Clinical
comparison of sevoflurane and isoflurane in healthy patients. Anesth Analg 74:241–245,
1992.
188.
Ebert TJ, Muzi M, Lopatka CW: Neurocirculatory
responses to sevoflurane in humans: A comparison to desflurane. Anesthesiology
83:88–95, 1995.
189.
Eger EI II: The pharmacology of isoflurane.
Br J Anaesth 56:71S–99S, 1984.
190.
Eger EI II: Nitrous Oxide: N2
O.
New York, Elsevier, 1985.
191.
Bahlman SH, Eger EI II, Halsey MJ, et al: The
cardiovascular effects of halothane in man during spontaneous ventilation. Anesthesiology
36:494–502, 1972.
192.
Price HL, Skovsted P, Pauca AL, Cooperman LH:
Evidence for β-receptor activation produced by halothane in normal man. Anesthesiology
32:389–395, 1970.
193.
Blake DW, Way D, Trigg L, et al: Cardiovascular
effects of volatile anesthesia in rabbits: Influence of chronic heart failure and
enalaprilat treatment. Anesth Analg 73:441–448, 1991.
194.
Reiz S: Nitrous oxide augments the systemic and
coronary haemodynamic effects of isoflurane in patients with ischaemic heart disease.
Acta Anaesthesiol Scand 27:464–469, 1983.
195.
Rydvall A, Haggmark S, Nyhman H, Reiz S: Effects
of enflurane on coronary haemodynamics in patients with ischaemic heart disease.
Acta Anaesthesiol Scand 28:690–695, 1984.
196.
Braunwald E: Pathophysiology of heart failure.
In Braunwald E (ed): Heart Disease: A Textbook
of Cardiovascular Medicine, 4th ed. Philadelphia, WB Saunders, 1992, pp 393–418.
197.
Atlee JL III, Brownlee SW, Burstrom RE: Conscious-state
comparisons of the effects of inhalational anesthetics on specialized atrioventricular
conduction times in dogs. Anesthesiology 64:703–710, 1986.
198.
Seagard JL, Bosnjak ZJ, Hopp FA Jr, et al: Cardiovascular
effects of anesthesia. In Covino BG, Fozzard HA,
Rehder K, Strichartz G (eds): Effects of Anesthesia. Bethesda, MD, American Physiological
Society, 1985, pp 149–177.
199.
Turner LA, Bosnjak ZJ, Kampine JP: Actions of
halothane on the electrical activity of Purkinje fibers derived from normal and infarcted
canine hearts. Anesthesiology 67:619–629, 1987.
200.
Atlee JL III, Rusy BF: Atrioventricular conduction
times and atrioventricular nodal conductivity during enflurane anesthesia in dogs.
Anesthesiology 47:498–503, 1977.
201.
Hauswirth O: Effects of halothane on single atrial,
ventricular and Purkinje fibers. Circ Res 24:745–750, 1969.
202.
Atlee JL III, Rusy BF, Kreul JF, Eby T: Supraventricular
excitability in dogs during anesthesia with halothane and enflurane. Anesthesiology
49:407–413, 1978.
203.
Atlee JL III, Yeager TS: Electrophysiologic assessment
of the effects of enflurane, halothane, and isoflurane on properties affecting supraventricular
re-entry in chronically instrumented dogs. Anesthesiology 71:941–952, 1989.
204.
Atlee JL III, Bosnjak Z: Mechanisms for cardiac
dysrhythmias during anesthesia. Anesthesiology 72:347–374, 1990.
205.
Atlee JL III, Bosnjak ZJ, Yeager TS: Effects
of diltiazem, verapamil, and inhalation anesthetics on electrophysiologic properties
affecting reentrant supraventricular tachycardia in chronically instrumented dogs.
Anesthesiology 72:889–901, 1990.
206.
MacLeod BA, Augereau P, Walker MJA: Effects of
halothane anesthesia compared with fentanyl anesthesia and no anesthesia during coronary
ligation in rats. Anesthesiology 58:44–52, 1983.
207.
Jang JL, MacLeod BA, Walker MJA: Effects of halogenated
hydrocarbon anesthetics on responses to ligation of a coronary artery in chronically
prepared rats. Anesthesiology 59:309–315, 1983.
208.
Kroll DA, Knight PR: Antifibrillatory effects
of volatile anesthetics in acute occlusion/reperfusion arrhythmias. Anesthesiology
61:657–661, 1984.
209.
Morrow DH, Townley NT: Anesthesia and digitalis
toxicity: An experimental study. Anesth Analg 43:510–519, 1964.
210.
Turner LA, Polic S, Hoffmann RG, et al: Actions
of halothane and isoflurane on Purkinje fibers in the infarcted canine heart: Conduction,
regional refractoriness, and reentry. Anesth Analg 76:718–725, 1993.
211.
Turner LA, Polic S, Hoffmann RG, et al: Actions
of volatile anesthetics on ischemic and nonischemic Purkinje fibers in the canine
heart: Regional action potential characteristics. Anesth Analg 76:726–733,
1993.
212.
Schmeling WT, Warltier DC, McDonald DJ, et al:
Prolongation of the QT interval by enflurane, isoflurane, and halothane in humans.
Anesth Analg 72:137–144, 1991.
213.
Hanich RF, Levine JH, Spear JF, Moore EN: Autonomic
modulation of ventricular arrhythmia in cesium chloride-induced long QT syndrome.
Circulation 77:1149–1161, 1988.
214.
Atlee JL III, Malkinson CE: Potentiation by thiopental
of halothane-epinephrine-induced arrhythmias in dogs. Anesthesiology 57:285–288,
1982.
215.
Joas TA, Stevens WC: Comparison of the arrhythmic
doses of epinephrine during Forane, halothane, and fluroxene anesthesia in dogs.
Anesthesiology 35:48–53, 1971.
216.
Sumikawa K, Ishizaka N, Suzaki M: Arrhythmogenic
plasma levels of epinephrine during halothane, enflurane, and pentobarbital anesthesia
in the dog. Anesthesiology 58:322–325, 1983.
217.
MacCannell KL, Dresel PE: Potentiation by thiopental
of cyclopropane-adrenaline cardiac arrhythmias. Can J Physiol Pharmacol 42:627–639,
1964.
218.
Hayashi Y, Sumikawa K, Tashiro C, et al: Arrhythmogenic
threshold of epinephrine during sevoflurane, enflurane, and isoflurane anesthesia
in dogs. Anesthesiology 69:145–147, 1988.
219.
Turner LA, Marijic J, Kampine JP, Bosnjak ZJ:
A comparison of the effects of halothane and tetrodotoxin on regional repolarization
characteristics of canine Purkinje fibers. Anesthesiology 73:1158–1168, 1990.
220.
Turner LA, Vodanovic S, Hoffmann RG, et al: A
subtype of α1
adrenoceptor mediates depression of conduction in
Purkinje fibers exposed to halothane. Anesthesiology 82:1438–1446, 1995.
221.
Vodanovic S, Turner LA, Hoffmann RG, et al: Actions
of phenylephrine, isoproterenol, and epinephrine with halothane on endocardial conduction
and activation in canine left ventricular papillary muscles. Anesthesiology 87:117–126,
1997.
222.
Weiskopf RB, Eger EI II, Holmes MA, et al: Epinephrine-induced
premature ventricular contractions and changes in arterial blood pressure and heart
rate during I-653, isoflurane, and halothane anesthesia in swine. Anesthesiology
70:293–298, 1989.
223.
Woehlck HJ, Vicenzi MN, Bosnjak ZJ, Atlee JL III:
Anesthetics and automaticity of dominant and latent pacemakers in chronically instrumented
dogs. I. Methodology, conscious state, and halothane anesthesia: Comparison with
and without muscarinic blockade during exposure to epinephrine. Anesthesiology 79:1304–1315,
1993.
224.
Vicenzi MN, Woehlck HJ, Bosnjak ZJ, Atlee JL III:
Anesthetics and automaticity of dominant and latent pacemakers in chronically instrumented
dogs. II. Effects of enflurane and isoflurane during epinephrine with and without
muscarinic blockade. Anesthesiology 79:1316–1323, 1993.
225.
Vicenzi MN, Woehlck HJ, Bajic J, et al: Anesthetics
and automaticity of dominant and latent pacemakers in chronically instrumented dogs.
III. Automaticity after sinoatrial node excision. Anesthesiology 82:469–478,
1995.
226.
Woehlck HJ, Vicenzi MN, Bajic J, et al: Anesthetics
and automaticity of dominant and latent pacemakers in chronically instrumented dogs.
IV. Dysrhythmias after sinoatrial node excision. Anesthesiology 82:1447–1455,
1995.
227.
Blaise G, Sill JC, Nugent M, et al: Isoflurane
causes endothelium-dependent inhibition of contractile responses of canine coronary
arteries. Anesthesiology 67:513–517, 1987.
228.
Bollen BA, Tinker JH, Hermsmeyer K: Halothane
relaxes previously constricted isolated porcine coronary artery segments more than
isoflurane. Anesthesiology 66:748–752, 1987.
229.
Bollen BA, McKlveen RE, Stevenson JA: Halothane
relaxes preconstricted small and medium isolated porcine coronary artery segments
more than isoflurane. Anesth Analg 75:9–17, 1992.
230.
Bollen BA, McKlveen RE, Stevenson JA: Halothane
relaxes previously constricted human epicardial coronary artery segments more than
isoflurane. Anesth Analg 75:4–8, 1992.
231.
Hatano Y, Nakamura K, Yakushiji T, et al: Comparison
of the direct effects of halothane and isoflurane on large and small coronary arteries
isolated from dogs. Anesthesiology 73:513–517, 1990.
232.
Marijic J, Buljubasic N, Coughlan G, et al: Effect
of K+
channel blockade with tetraethylammonium on anesthetic-induced relaxation
in canine cerebral and coronary arteries. Anesthesiology 77:948–855, 1992.
233.
Villeneuve E, Blaise G, Sill JC, et al: Halothane
1.5 MAC, isoflurane 1.5 MAC, and the contractile responses of coronary arteries obtained
from human hearts. Anesth Analg 72:454–461, 1991.
234.
Witzeling TM, Sill JC, Hughes JM, et al: Isoflurane
and halothane attenuate coronary artery constriction evoked by serotonin in isolated
porcine vessels and in intact pigs. Anesthesiology 73:100–108, 1990.
235.
Buljubasic N, Rusch NJ, Marijic J, et al: Effects
of halothane and isoflurane on calcium and potassium channel currents in canine coronary
arterial cells. Anesthesiology 76:990–998, 1992.
236.
Kersten JR, Warltier DC: The coronary circulation.
In Yaksh TL, Lynch C III, Zapol WM, et al (eds):
Anesthesia: Biologic Foundations. Philadelphia, Lippincott-Raven, 1997, pp 1169–1192.
237.
Larach DR, Schuler HG, Skeehan TM, Peterson CJ:
Direct effects of myocardial depressant drugs on coronary vascular tone: Anesthetic
vasodilation by halothane and isoflurane. J Pharmacol Exp Ther 254:58–64,
1990.
238.
Sahlman L, Henriksson B-A, Martner J, Ricksten
SE: Effects of halothane, enflurane, and isoflurane on coronary vascular tone, myocardial
performance, and oxygen consumption during controlled changes in aortic and left
atrial pressure. Studies on isolated working rat hearts in vitro. Anesthesiology
69:1–10, 1988.
239.
Stowe DF, Marijic J, Bosnjak ZJ, Kampine JP:
Direct comparative effects of halothane, enflurane, and isoflurane on oxygen supply
and demand in isolated hearts. Anesthesiology 74:1087–1095, 1991.
240.
Stowe DF, Monroe SM, Marijic J, et al: Comparison
of halothane, enflurane, and isoflurane with nitrous oxide on contractility and oxygen
supply and demand in isolated hearts. Anesthesiology 75:1062–1074, 1991.
241.
Larach DR, Schuler HG: Direct vasodilation by
sevoflurane, isoflurane, and halothane alters coronary flow reserve in the isolated
rat heart. Anesthesiology 75:268–278, 1991.
242.
Smith G, Vance JP, Brown DM, McMillan JC: Changes
in myocardial blood flow and oxygen consumption in response to halothane. Br J Anaesth
46:821–826, 1974.
243.
Domenech RJ, Macho P, Valdes J, Penna M: Coronary
vascular resistance during halothane anesthesia. Anesthesiology 46:236–240,
1977.
244.
Weaver PC, Bailey JS, Preston TD: Coronary artery
blood flow in the halothane-depressed canine heart. Br J Anaesth 42:678–684,
1970.
245.
Wolff G, Claudi B, Rist M, et al: Regulation
of coronary blood flow during ether and halothane anaesthesia. Br J Anaesth 44:1139–1149,
1972.
246.
Amory DW, Steffenson JL, Forsyth RP: Systemic
and regional blood flow changes during halothane anesthesia in the rhesus monkey.
Anesthesiology 35:81–90, 1971.
247.
Vatner SF, Smith NT: Effects of halothane on
left ventricular function and distribution of regional blood flow in dogs and primates.
Circ Res 34:155–167, 1974.
248.
Brett CM, Teitel DF, Heymann MA, Rudolph AM:
The cardiovascular effects of isoflurane in lambs. Anesthesiology 67:60–65,
1987.
249.
Crystal GJ, Kim S-J, Czinn EA, et al: Intracoronary
isoflurane causes marked vasodilation in canine hearts. Anesthesiology 74:757–765,
1991.
250.
Hickey RF, Cason BA, Shubayev I: Regional vasodilating
properties of isoflurane in normal swine myocardium. Anesthesiology 80:574–581,
1994.
251.
Priebe H-J: Differential effects of isoflurane
on regional right and left ventricular performances, and on coronary, systemic, and
pulmonary hemodynamics in the dog. Anesthesiology 66:262–272, 1987.
252.
Kenny D, Proctor LT, Schmeling WT, et al: Isoflurane
causes only minimal increases in coronary blood flow independent of oxygen demand.
Anesthesiology 75:640–649, 1991.
253.
Crystal GJ, Kim S-J, Salem MR, et al: Nitric
oxide does not mediate coronary vasodilation by isoflurane. Anesthesiology 81:209–220,
1994.
254.
Sill JC, Bove AA, Nugent M, et al: Effects of
isoflurane on coronary arteries and coronary arterioles in the intact dog. Anesthesiology
66:273–279, 1987.
255.
Hickey RF, Sybert PE, Verrier ED, Cason BA: Effects
of halothane, enflurane, and isoflurane on coronary blood flow autoregulation and
coronary vascular reserve in the canine heart. Anesthesiology 68:21–30, 1988.
256.
Conzen PF, Hobbhahn J, Goetz AE, et al: Regional
blood flow and tissue oxygen pressures of the collateral-dependent myocardium during
isoflurane anesthesia in dogs. Anesthesiology 70:442–452, 1989.
257.
Habazettl H, Conzen PF, Hobbhahn J, et al: Left
ventricular oxygen tensions in dogs during coronary vasodilation by enflurane, isoflurane
and dipyridamole. Anesth Analg 68:286–294, 1989.
258.
Boban M, Stowe DF, Buljubasic N, et al: Direct
comparative effects of isoflurane and desflurane in isolated guinea pig hearts.
Anesthesiology 76:775–780, 1992.
259.
Conzen PF, Vollmar B, Habazettl H, et al: Systemic
and regional hemodynamics of isoflurane and sevoflurane in rats. Anesth Analg 74:79–88,
1992.
260.
Crawford MW, Lerman J, Saldivia V, Carmichael
FJ: Hemodynamic and organ blood flow responses to halothane and sevoflurane anesthesia
during spontaneous ventilation. Anesth Analg 75:1000–1006, 1992.
261.
Manohar M, Parks CM: Porcine systemic and regional
organ blood flow during 1.0 and 1.5 minimum alveolar concentrations of sevoflurane
anesthesia without and with 50% nitrous oxide. J Pharmacol Exp Ther 231:640–648,
1984.
262.
Gilbert M, Roberts SL, Mori M, et al: Comparative
coronary vascular reactivity and hemodynamics during halothane and isoflurane anesthesia
in swine. Anesthesiology 68:243–253, 1988.
263.
Conzen PF, Habazettl H, Vollmar B, et al: Coronary
microcirculation during halothane, enflurane, isoflurane, and adenosine in dogs.
Anesthesiology 76:261–270, 1992.
264.
Ozhan M, Sill JC, Atagunduz P, et al: Volatile
anesthetics and agonist-induced contractions in porcine coronary artery smooth muscle
and Ca2+
mobilization in cultured immortalized vascular smooth muscle
cells. Anesthesiology 80:1102–1113, 1994.
265.
Su JY, Zhang CC: Intracellular mechanisms of
halothane's effect on isolated aortic strips of the rabbit. Anesthesiology 71:409–417,
1989.
266.
Sill JC, Eskuri S, Nelson R, et al: The volatile
anesthetic isoflurane attenuates Ca2+
mobilization in cultured vascular
smooth muscle cells. J Pharmacol Exp Ther 265:74–80, 1993.
267.
Brendel JK, Johns RA: Isoflurane does not dilate
isolated rat thoracic aortic rings by endothelium-derived relaxing factor or other
cyclic GMP-mediated mechanisms. Anesthesiology 77:126–131, 1992.
268.
Muldoon SM, Hart JL, Bowen KA, Freas W: Attenuation
of endothelium-mediated vasodilation by halothane. Anesthesiology 68:31–37,
1988.
269.
Stone DJ, Johns RA: Endothelium-dependent effects
of halothane, enflurane, and isoflurane on isolated rat aortic vascular rings. Anesthesiology
71:126–132, 1989.
270.
Greenblatt EP, Loeb AL, Longnecker DE: Endothelium-dependent
circulatory control—A mechanism for the differing peripheral vascular effects
of isoflurane versus halothane. Anesthesiology 77:1178–1185, 1992.
271.
Blaise G, To Q, Parent M, et al: Does halothane
interfere with the release, action, or stability of endothelium-derived relaxing
factor/nitric oxide? Anesthesiology 80:417–426, 1994.
272.
Uggeri MJ, Proctor GJ, Johns RA: Halothane, enflurane,
and isoflurane attenuate both receptor- and non-receptor-mediated EDRF production
in rat thoracic aorta. Anesthesiology 76:1012–1017, 1992.
273.
Hart JL, Jing M, Bina S, et al: Effects of halothane
on EDRF/cGMP-mediated vascular smooth muscle relaxations. Anesthesiology 79:323–331,
1993.
274.
Toda H, Nakamura K, Hatano Y, et al: Halothane
and isoflurane inhibit endothelium-dependent relaxation elicited by acetylcholine.
Anesth Analg 75:198–203, 1992.
275.
Yoshida K-I, Okabe E: Selective impairment of
endothelium-dependent relaxation by sevoflurane: Oxygen free radicals participation.
Anesthesiology 76:440–447, 1992.
276.
Larach DR, Schuler HG: Potassium channel blockade
and halothane vasodilation in conducting and resistance coronary arteries. J Pharmacol
Exp Ther 267:72–81, 1993.
277.
Cason BA, Shubayev I, Hickey RF: Blockade of
adenosine triphosphate-sensitive potassium channels eliminates isoflurane-induced
coronary artery vasodilation. Anesthesiology 81:1245–1255, 1994.
278.
Crystal GJ, Gurevicius J, Salem MR, Zhou X: Role
of adenosine triphosphate-sensitive potassium channels in coronary vasodilation by
halothane, isoflurane, and enflurane. Anesthesiology 86:448–458, 1997.
279.
Kersten JR, Schmeling TJ, Hettrick DA, et al:
Mechanism of cardioprotection by isoflurane: Role of adenosine triphosphate-regulated
potassium (KATP) channels. Anesthesiology 85:794–807, 1996.
280.
Kersten JR, Gross GJ, Pagel PS, Warltier DC:
Activation of adenosine triphosphate-regulated potassium channels: Mediation of
cellular and organ protection. Anesthesiology 88:495–513, 1998.
281.
Hickey RF, Verrier ED, Baer RW, et al: A canine
model of acute coronary stenosis: Effects of deliberate hypotension. Anesthesiology
59:226–236, 1983.
282.
Priebe H-J, Foex P: Isoflurane causes regional
myocardial dysfunction in dogs with critical coronary artery stenoses. Anesthesiology
66:293–300, 1987.
283.
Foex P, Francis CM, Cutfield GR, Leone B: The
pressure-length loop. Br J Anaesth 60(Suppl 1):65S–71S, 1988.
284.
Priebe H-J: Isoflurane causes more severe myocardial
dysfunction than halothane in dogs with a critical coronary stenosis. Anesthesiology
69:72–83, 1988.
285.
Tatekawa S, Traber KB, Hantler CB, et al: Effects
of isoflurane on myocardial blood flow, function, and oxygen consumption in the presence
of critical coronary stenosis in dogs. Anesth Analg 66:1073–1082, 1987.
286.
Wilton NCT, Knight PR, Ullrich K, et al: Transmural
redistribution of myocardial blood flow during isoflurane anesthesia and its effects
on regional myocardial function in a canine model of fixed coronary stenosis. Anesthesiology
78:510–523, 1993.
287.
Cason BA, Verrier ED, London MJ, et al: Effects
of isolfurane and halothane on coronary vascular resistance and collateral myocardial
blood flow: Their capacity to induce coronary steal. Anesthesiology 67:665–675,
1987.
288.
Hartman JC, Kampine JP, Schmeling WT, Warltier
DC: Actions of isoflurane on myocardial perfusion in chronically instrumented dogs
with poor, moderate, or well-developed coronary collaterals. J Cardiothorac Anesth
4:715–725, 1990.
289.
Hartman JC, Kampine JP, Schmeling WT, Warltier
DC: Alterations in collateral blood flow produced by isoflurane in a chronically
instrumented canine model of multivessel coronary artery disease. Anesthesiology
74:120–133, 1991.
290.
Hartman JC, Kampine JP, Schmeling WT, Warltier
DC: Volatile anesthetics and regional myocardial perfusion in chronically instrumented
dogs: Halothane versus isoflurane in a single-vessel disease model with enhanced
collateral development. J Cardiothorac Anesth 4:588–603, 1990.
291.
Hartman JC, Kampine JP, Schmeling WT, Warltier
DC: Steal-prone coronary circulation in chronically instrumented dogs: Isoflurane
versus adenosine. Anesthesiology 74:744–756, 1991.
292.
Moore PG, Kien ND, Reitan JA, et al: No evidence
for blood flow redistribution with isoflurane or halothane during acute coronary
artery occlusion in fentanyl-anesthetized dogs. Anesthesiology 75:854–865,
1991.
293.
Hartman JC, Pagel PS, Kampine JP, et al: Influence
of desflurane on the regional distribution of coronary blood flow in a chronically
instrumented canine model of multivessel coronary artery obstruction. Anesth Analg
72:289–299, 1991.
294.
Kersten JR, Brayer AP, Pagel PS, et al: Perfusion
of ischemic myocardium during anesthesia with sevoflurane. Anesthesiology 81:995–1004,
1994.
295.
Buffington CW, Romson JL, Levine A, et al: Isoflurane
induces coronary steal in a canine model of chronic coronary occlusion. Anesthesiology
66:280–292, 1987.
296.
Cheng DCH, Moyers JR, Knutson RM, et al: Dose-response
relationship of isoflurane and halothane versus coronary perfusion pressures: Effects
on flow redistribution in a collateralized chronic swine model. Anesthesiology 76:113–122,
1992.
297.
Bland JHL, Lowenstein E: Halothane-induced decrease
in experimental myocardial ischemia in the non-failing canine heart. Anesthesiology
45:287–293, 1976.
298.
Gerson JI, Hickey RF, Bainton CR: Treatment of
myocardial ischemia with halothane or nitroprusside-propranolol. Anesth Analg 61:10–14,
1982.
299.
Davis RF, Sidi A: Effect of isoflurane on the
extent of myocardial necrosis and on systemic hemodynamics, regional myocardial blood
flow, and regional myocardial metabolism in dogs after coronary artery occlusion.
Anesth Analg 69:575–586, 1989.
300.
Cope DK, Impastato WK, Cohen MV, Downey JM: Volatile
anesthetics protect the ischemic rabbit myocardium from infarction. Anesthesiology
86:699–709, 1997.
